Evolent Health, Inc. revenue
Evolent Health, Inc.'s revenue was $1.88bn in fiscal 2025, down 26.6% on the year before. Since fiscal 2016 ($254m) it has grown at a compound 24.9% a year. Over the last twelve months it was $2.10bn.
Revenue history
| Fiscal year | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 254 | 435 | 627 | 687 | 925 | 908 | 1,352 | 1,964 | 2,555 | 1,876 | 2,097 |
| Growth on the year before | — | +71.1% | +44.2% | +9.6% | +34.6% | −1.8% | +48.9% | +45.3% | +30.1% | −26.6% | — |
| Gross profit | — | — | — | — | — | 250 | 317 | 460 | 367 | 400 | 362 |
Where the revenue comes from
| Line of business | Revenue | YoY |
|---|---|---|
| Evolent Health Services | $1.9B | ▼ 26.6% |
| Reportable | $1.9B | ▼ 26.6% |
These categories overlap or exclude eliminations, so shares aren't shown.
From Evolent Health, Inc.'s 10-K filed February 25, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Evolent Health, Inc. | $2.10bn | -4.5% | 8.7% |
| Radnet, Inc. | $2.27bn | 18.9% | 14.1% |
| Privia Health Group, Inc. | $2.36bn | 24.1% | 16.1% |
| Hims & Hers Health, Inc. | $2.58bn | 28.0% | 53.7% |
| Aveanna Healthcare Holdings, Inc. | $2.60bn | 19.5% | 12.4% |
| Chemed Corp | $2.66bn | 5.2% | 6.1% |
Compare with peers
- Radnet, Inc. revenue
- Privia Health Group, Inc. revenue
- Hims & Hers Health, Inc. revenue
- Aveanna Healthcare Holdings, Inc. revenue
- Chemed Corp revenue
Head to head: EVH vs RDNTEVH vs PRVAEVH vs HIMS
More: Health Care Services stocks compared, Health Care sector, rankings of US companies